Skip to main content
TipRanks
Go Ultimate75% OFF

Compare CARsgen Therapeutics Holdings Ltd. (CRTHF) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CRTHFCARsgen Therapeutics Holdings Ltd.$1.42$739.92M-49.33134.71%―Unlock the CRTHF analyst price target with TipRanks PremiumCRTHFUnlock the CRTHF top-analyst price target with TipRanks Premium
HK:9688Zai Lab LtdHKD 16.39HKD 21.79B-11.561.93%Moderate BuyUnlock the HK:9688 analyst price target with TipRanks PremiumCRTHF vs HK:9688Unlock the HK:9688 top-analyst price target with TipRanks Premium
HK:9966Alphamab OncologyHKD 5.11HKD 5.19B-25.31-50.39%―Unlock the HK:9966 analyst price target with TipRanks PremiumCRTHF vs HK:9966Unlock the HK:9966 top-analyst price target with TipRanks Premium
HK:1877Shanghai Junshi Biosciences Co., Ltd. Class HHKD 13.20HKD 27.72B-60.03-46.25%Strong BuyUnlock the HK:1877 analyst price target with TipRanks PremiumCRTHF vs HK:1877Unlock the HK:1877 top-analyst price target with TipRanks Premium
HK:2126JW (Cayman) Therapeutics Co. Ltd.HKD 1.98HKD 890.05M-2.11-38.70%―Unlock the HK:2126 analyst price target with TipRanks PremiumCRTHF vs HK:2126Unlock the HK:2126 top-analyst price target with TipRanks Premium
HK:2616CStone PharmaceuticalsHKD 5.68HKD 9.45B-17.91-5.02%Moderate BuyUnlock the HK:2616 analyst price target with TipRanks PremiumCRTHF vs HK:2616Unlock the HK:2616 top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CRTHFCARsgen Therapeutics Holdings Ltd.1.420.81134.71%
HK:9688Zai Lab Ltd16.390.805.13%
HK:9966Alphamab Oncology5.11-4.74-48.12%
HK:1877Shanghai Junshi Biosciences Co., Ltd. Class H13.20-10.60-44.54%
HK:2126JW (Cayman) Therapeutics Co. Ltd.1.98-1.24-38.51%
HK:2616CStone Pharmaceuticals5.680.061.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts